Inflammatory Bowel Disease

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.
Dr Siegel, from Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, previews his address at the Advances in Inflammatory Bowel Diseases regional meeting on March 6 on options for treating inflammatory bowel diseases, ranging from hyperbaric oxygen to combining biologics and more.
Dr Kochar, from Massachusetts General Hospital, discusses the particular concerns of older patients with inflammatory bowel disease, how this population is growing, and what research is showing regarding the best options for treatment.
In this video, Dr Horst, from Vanderbilt University, provides guidance on how to help patients with inflammatory bowel disease make small lifestyle changes that can lead to better outcomes through health coaching.
Dr Holubar, from the Cleveland Clinic, discusses new surgical advances in treating ileocolic Crohn disease, including Kono-S anastamosis and extended mesenteric excision.
In this Q&A, Dr Carreras-Torres, from the Bellvitge Biomedical Research Institute in Barcelona, Spain, discusses his research into factors that can increase the risk of developing, and worsen the course of existing, inflammatory bowel disease.
Dr Horst, from Vanderbilt University Medical Center and Section Editor in inflammatory bowel disease for the Gastroenterology Learning Network, cautions that physicians often believe their patients with inflammatory bowel disease are more adherent to their medication regimens than they are.
Dr Holubar, from the Cleveland Clinic, discusses his research into the question of whether patients who take biologic therapies prior to surgery for IBD are more likely to develop postoperative complications.
Dr Caldera, from the University of Wisconsin, discusses the safety of COVID-19 immunization for patients with IBD, and how to work with these patients to ensure they receive all the vaccinations they need.
Dr Cohen, director of the IBD Center at the University of Chicago, recaps his presentation at the Crohn's & Colitis Congress 2021 on using novel small molecule agents to treat inflammatory bowel disease.
In this video, Dr Hanauer, from the Feinberg School of Medicine at Northwestern University in Chicago, reviews his presentation at the Crohn's & Colitis Congress 2021 on "evolutionary" agents on the horizon for treatment of inflammatory bowel disease.
In this video, Dr Abreu, director of the Crohn's and Colitis Center at the University of Miami Miller School of Medicine, previews her talk for the Crohn's & Colitis Congress 2021 on how basic research is being translated to advances in direct care for patients with inflammatory bowel disease.